King Saud University
  Help (new window)
Search


Guidelines_English_Final
تحميل الدليل التدريبي

أسئلة شائعة


 

PHCL 501 THERAPEUTICS I (3+1)

A. COURSE DESCRIPTION:

The Therapeutics  Courses I,II and II  are post-graduate  pharmacy courses designed to provide students with an opportunity to apply their  knowledge  of  the basic pharmaceutical  sciences  and  to obtain new information about rational drug therapy to promote the practice of patient oriented pharmacy.

 The courses consist of both lectures and conferences.  Students will  gain  an  understanding of rational  drug  therapy  in  the treatment   of  selected  diseases;  problems   associated   with implementing   rational  drug  therapy;  how   therapy   concepts correlate  with  the  pathophysiology of  the  disease;  and  the monitoring  tools  necessary  for  evaluation  of  drug  therapy. Students will be expected to correlate the findings of case study with the drug therapy and disease.

 

B. COURSE OBJECTIVES:

By the successful completion of this course, students will be able to:

1. Discuss pathophysiology of selected diseases, including    pathogenesis, signs and symptoms and common laboratory findings as well as complicating factors.

2.  Apply knowledge of pertinent chemical, physical, and           pharmaceutical properties of drugs as they relate to drug   disposition,   stability   and   handling   when evaluating therapeutic regimens.

 

3.   Apply  pertinent pharmaceutical principles when evaluating a therapeutic problem such as adjustment  of the  dose or regimen for certain drugs in the  presence  of  renal  or  liver  dysfunction  or  other diseases affecting drug absorption or disposition.

 

4.       Evaluate day-by-day multiple drug therapy with particular attention placed on the pharmacist's role in recognizing and monitoring for drug efficacy and giving alternative treatment plans.

 

5.   Utilize common clinical laboratory tests and evaluate their usefulness in monitoring the progress of the disease and/or drug therapy.

 

6.     Assess the   multiple factors which affect the patient's response to drug therapy regimens.

 

7.     Use the information from the biomedical and pharmaceutical literature to evaluate and   solve problems concerning drug therapy.

 

8.     Read and interpret information found in medical records and create a pertinent data base in a problem-oriented manner.

  

9.     Develop communication skills both formal and informal with peers, other health professionals, and patients.  Students   will demonstrate an ability to   gather, organize and articulately present material in response to drug-use questions.

 

10.  Understand the role of other health professionals with whom the pharmacist interacts in patient care and develop a sense of the pharmacist's role as member of the health care team.

 

C. COURSE FORMAT

Advanced Therapeutic I, II and III will consist of three 1 hr lectures and 3-hour conference per week. Selected topics from  diseases  of major  organ  systems  will be presented each  week  followed  by conference discussions the following week to enhance  understanding  of  the  topic  presented  through  case   history analysis.

 

D. CONFERENCE GUIDELINES:

 

          Conferences are designed to allow students to discuss the topic presented the previous week in lecture.  An abstract of a patient's case history is used as part of the discussion.  During the  conference,  aspects of the lectures are  blended  with  the findings  and  development  of the  case  study  with  particular emphasis  being placed on the contribution that a pharmacist  can make. Areas for discussion each week will include:

 

A)    presentation of the case study-summary of pertinent positive and negative findings; special observations,                     findings or considerations of the case study.

 

b)    drug monitoring parameters - means  by  which  the pharmacist  should monitor drug therapy, ADR,  SE,  and the  progress  of  the disease as  it  relates  to  the specific  case  study and the drug  therapy/disease  in general.

 

c)    rational/irrational therapy-alternatives to the therapy in the case study; advantages and disadvantages to alternative therapy; dosing considerations.

 

d)    Patient education and considerations - factors that should be considered when preparing and providing patient counseling; issues surrounding compliance and ways to encourage it.

 

PHCL 501 ADVANCE THERAPEUTICS - I (3 + 1) 

WK #            TOPIC OF THE WEEK                               

 

1                  Orientation                                          

 

2                  Cardiac arrhythmia (I)                                     

 

3                  Cardiac arrhythmia (II)                                    

 

4                  Pediatric respiratory diseases                  

 

5                 Chronic complications of D.M.                                              

 

6                  Hyperlipidemia                                                

 

7                 Acute MI/CHF                                                

 

8                 Hypertensive crisis                                         

 

9                 Thrombolytic therapy                        

 

10                Midterm Exam.

 

11               Hepatitis                                                                

 

12               Viral and parasitic infections          

 

13               Neoplastic diseases and pain management.                                      

 

14                Pediatric neoplastic disorders

 

15               Study week                                         

 

16                Final exam. week

 

King   Saud University. All rights reserved, 2007 | Disclaimer | CiteSeerx